Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Chronic Postsurgical Pain After Lung Surgery
2020-003300-14Phase 2Terminated
- Sponsor
- Aalborg University Hospital
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of botulinum toxin type A in post-thoracotomy pain syndrome (PTPS), sponsored by Aalborg University Hospital. Primary endpoint: Recruitment feasibility. Started Aug 2020; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
post-thoracotomy pain syndrome (PTPS)
Beyond the preview
Go deeper on 2020-003300-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003300-14.